WAYNE, Pa., Aug. 26, 2014 /PRNewswire-USNewswire/ -- Ryan
& Maniskas, LLP is investigating potential claims against the
board of directors of InterMune, Inc. ("InterMune" or the
"Company") (NASDAQ: ITMN) concerning possible breaches of fiduciary
duty and other violations of law related to the Company's efforts
to sell the Company to Roche Holdings, Inc. in a transaction valued
at approximately $8.3 billion.
If you own shares of InterMune and would like to learn more
about this class action or if you wish to discuss these matters and
have any questions concerning this announcement or your rights,
contact Richard A. Maniskas, Esquire
toll-free at (877) 316-3218 or to sign up online, visit:
www.rmclasslaw.com/cases/itmn. You may also email Mr. Maniskas at
rmaniskas@rmclasslaw.com.
Under the terms of the agreement, shareholders of InterMune
would receive $74.00 in cash for each
share of InterMune they own.
Our investigation concerns possible breaches of fiduciary duty
and other violations of state law by the Board of Directors of
InterMune for not acting in the Company's shareholders' best
interests in connection with the sale process.
Ryan & Maniskas, LLP is a national shareholder litigation
firm. Ryan & Maniskas, LLP is devoted to protecting the
interests of individual and institutional investors in shareholder
actions in state and federal courts nationwide. To learn more
about the class action process, please visit:
www.rmclasslaw.com.
CONTACT:
|
Ryan &
Maniskas, LLP
|
|
Richard A.
Maniskas, Esquire
|
|
995 Old Eagle
School Rd., Suite 311
|
|
Wayne, PA
19087
|
|
877-316-3218
|
|
www.rmclasslaw.com/cases/itmn
|
|
rmaniskas@rmclasslaw.com
|
Logo -
http://photos.prnewswire.com/prnh/20121112/MM11729LOGO
SOURCE Ryan & Maniskas, LLP